Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bieche

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept studyL Cabel, F Riva, V Servois, et al.
British Journal of Cancer|July 16, 2009
Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressivenessL-B Weiswald, S Richon, P Validire, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2018
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trialM Arnedos, M A Bayar, B Cheaib, et al.
Journal of Hematology & Oncology|February 24, 2020
Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancersF Coussy, R El Botty, M Lavigne, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2018
Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survivalC Dubot, V Bernard, M P Sablin, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2019
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular TargetsA Moreira, J Masliah-Planchon, C Callens, et al.
Oncogene|November 28, 2018
ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumorsG Vargas, M Bouchet, L Bouazza, et al.
Breast Cancer Research and Treatment|April 6, 2012
Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predispositionE Rouleau, B Jesson, A Briaux, et al.
ESMO Open|June 12, 2021
Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgeryA Moreira, A Poulet, J Masliah-Planchon, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept studyL Cabel, F Riva, V Servois, et al.
British Journal of Cancer|July 16, 2009
Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressivenessL-B Weiswald, S Richon, P Validire, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2018
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trialM Arnedos, M A Bayar, B Cheaib, et al.
Journal of Hematology & Oncology|February 24, 2020
Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancersF Coussy, R El Botty, M Lavigne, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2018
Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survivalC Dubot, V Bernard, M P Sablin, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2019
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular TargetsA Moreira, J Masliah-Planchon, C Callens, et al.
Oncogene|November 28, 2018
ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumorsG Vargas, M Bouchet, L Bouazza, et al.
Breast Cancer Research and Treatment|April 6, 2012
Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predispositionE Rouleau, B Jesson, A Briaux, et al.
ESMO Open|June 12, 2021
Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgeryA Moreira, A Poulet, J Masliah-Planchon, et al.
Pageof 4